8 research outputs found
SHIP2: A ‘‘NEW’’ Insulin Pathway Target for Aging Research
Strong evidence suggests that systemic inflammation and central adiposity contribute to and perpetuate metabolic
syndrome. All of these alterations predispose individuals to type 2 diabetes mellitus (T2DM), cardiovascular
disease, as well as Alzheimer’s disease (AD), all characterized by chronic inflammatory status. On the
other hand, extensive abnormalities in insulin and insulin-like growth factor I (IGF-I) and IGF-II signaling
mechanisms in brains with AD have been demonstrated, suggesting that AD could be a third form of diabetes.
The Src homology domain-containing inositol 5-phosphatase 2 (SHIP2) has an important role in the insulin
pathway because its over-expression causes impairment of insulin/IGF-1 signaling. Because some singlenucleotide
polymorphisms (SNP) of the gene encoding SHIP2 were significantly associated in T2DM patients
with metabolic syndrome and some related conditions, we decided to conduct a case–control study on this gene,
analyzing AD and T2DM subjects as cases and young, old, and centenarians as controls. Our results suggest a
putative correlation between the the rs144989913 SNP and aging, both successful and unsuccessful, rather than
age-related diseases. Because this SNP is an insertion/deletion of 28 bp, it might cause an alteration in SHIP2
expression. It is noteworthy that SHIP2 has been demonstrated to be a potent negative regulator of insulin
signaling and insulin sensitivity. Many studies demonstrated the association of the insulin/IGF1 pathway with
aging and longevity, so it is tempting to speculate that the found association with SHIP2 and aging might
depend on its effect on the insulin/IGF-1 pathwa
Nutrient sensing pathways as therapeutic targets for healthy ageing
Introduction: In the present paper, the authors have discussed anti-aging strategies which aim to slow the aging process and to delay the onset of age-related diseases, focusing on nutrient sensing pathways (NSPs) as therapeutic targets. Indeed, several studies have already demonstrated that both in animal models and humans, dietary interventions might have a positive impact on the aging process through the modulation of these pathways. Areas covered: Achieving healthy aging is the main challenge of the twenty-first century because lifespan is increasing, but not in tandem with good health. The authors have illustrated different approaches that can act on NSPs, modulating the rate of the aging process. Expert opinion: Humanity\u2019s lasting dream is to reverse or, at least, postpone aging. In recent years, increasing attention has been devoted to anti-aging therapies. The subject is very popular among the general public, whose imagination runs wild with all the possible tools to delay aging and to gain immortality. Some approaches discussed in the present review should be able to substantially slow down the aging process, extending our productive, youthful lives, without frailty
SHIP2: a "NEW" insulin pathway target for ageing research.
Strong evidence suggests that systemic inflammation and central adiposity contribute to and perpetuate metabolic syndrome. All of these alterations predispose individuals to type 2 diabetes mellitus (T2DM), cardiovascular disease, as well as Alzheimer's disease (AD), all characterized by chronic inflammatory status. On the other hand, extensive abnormalities in insulin and insulin-like growth factor I (IGF-I) and IGF-II signaling mechanisms in brains with AD have been demonstrated, suggesting that AD could be a third form of diabetes. The Src homology domain-containing inositol 5-phosphatase 2 (SHIP2) has an important role in the insulin pathway because its over-expression causes impairment of insulin/IGF-1 signaling. Because some single-nucleotide polymorphisms (SNP) of the gene encoding SHIP2 were significantly associated in T2DM patients with metabolic syndrome and some related conditions, we decided to conduct a case-control study on this gene, analyzing AD and T2DM subjects as cases and young, old, and centenarians as controls. Our results suggest a putative correlation between the the rs144989913 SNP and aging, both successful and unsuccessful, rather than age-related diseases. Because this SNP is an insertion/deletion of 28 bp, it might cause an alteration in SHIP2 expression. It is noteworthy that SHIP2 has been demonstrated to be a potent negative regulator of insulin signaling and insulin sensitivity. Many studies demonstrated the association of the insulin/IGF1 pathway with aging and longevity, so it is tempting to speculate that the found association with SHIP2 and aging might depend on its effect on the insulin/IGF-1 pathway